Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer.
Cancer Cell
; 41(8): 1427-1449.e12, 2023 08 14.
Article
in En
| MEDLINE
| ID: mdl-37478850
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
Limits:
Humans
/
Male
Language:
En
Journal:
Cancer Cell
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
United States